Mismatch repair proteins are activators of toxic responses to chromium-DNA damage

Molecular and Cellular Biology

Volumn 25, Issue 9, 2005, Pages 3596-3607

  Peterson Roth, Elizabeth ^a   Reynolds, Mindy ^a   Quievryn, George ^a   Zhitkovich, Anatoly ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; CASPASE 7; CHROMIUM; DOUBLE STRANDED DNA; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH6; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; CYTOTOXICITY; DNA ADDUCT; DNA DAMAGE; DNA STRAND BREAKAGE; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; GENE REPLICATION; HUMAN; HUMAN CELL; INTESTINE CELL; MISMATCH REPAIR; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANIMALS; APOPTOSIS; BASE PAIR MISMATCH; CARRIER PROTEINS; CASPASE 2; CASPASE 7; CASPASES; CELLS, CULTURED; CHROMIUM; COLON; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA-BINDING PROTEINS; FIBROBLASTS; G2 PHASE; HISTONES; HUMANS; MICE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 17644377918     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.9.3596-3607.2005     Document Type: Article

References (65)

1. Acharya, S., T. Wilson, S. Gradia, M. F. Kane, S. Guerrette, G. T. Marsischky, H. Kolodner, and R. Fishel. 1996. hMSH2 forms specific mispairbinding complexes with hMSH3 and hMSH6. Proc. Natl. Acad. Sci. USA 93:13629-13634.
2. Aebi, S., B. Kurdi-Haidar, R. Gordon, B. Cenni, H. Zheng, D. Fink, R. D. Christen, C. R. Boland, M. Koi, R. Fishel, and S. B. Howell. 1996. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56:3087-3090.
3. 2/M cell cycle arrest and lethality after DNA damage. Carcinogenesis 20:2317-2326.
4. Boyer, J. C., A. Umar, J. I. Risinger, J. R. Lipford, M. Kane, S. Yin, J. C. Barrett, R. D. Kolodner, and T. A. Kunkel. 1995. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res. 55:6063-6070.
5. Branch, P., G. Aquilina, M. Bignami, and P. Karran. 1993. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 362:652-654.
6. Brummelkamp, T. R., R. Bernards, and R. Agami. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
7. Canman, C. E., D. S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan, and J. D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679.
8. Carlisle, D. L., D. E. Pritchard, J. Singh, and S. R. Patierno. 2000. Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol. Carcinog. 28:111-118.
9. 2/M arrest requires a full complement of the mismatch repair protein hMLH1. EMBO J. 22:2245-2254.
10. Clark, A. B., and T. A. Kunkel. 2004. Cadmium inhibits the functions of eukaryotic MutS complexes. J. Biol. Chem. 279:53903-53906.
11. Courcelle, J., J. R. Donaldson, K. H. Chow, and C. T. Courcelle. 2003. DNA damage-induced replication fork regression and processing in Escherichia coli. Science 299:1064-1067.
12. Drotschmann, K., R. P. Topping, J. E. Clodfelter, and F. R. Salsbury. 2004. Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival. DNA Repair (Amsterdam) 3:729-742.
13. Duckett, D. R., J. T. Drummond, A. I. Murchie, J. T. Reardon, A. Sancar, D. M. Lilley, and P. Modrich. 1996. Human MutSα recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA 93:6443-6447.
14. Fishel, R. 1998. Mismatch repair, molecular switches, and signal transduction. Genes Dev. 12:2096-2101.
15. Genschel, J., S. J. Littman, J. T. Drummond, and P. Modrich. 1998. Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutSα. J. Biol. Chem. 273:19895-19901.
16. Gong, J. G., A. Costanzo, H. Q. Yang, G. Melino, W. G. Kaelin, Jr., M. Levrero, and J. Y. Wang. 1999. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806-809.
17. Ha, L., S. Ceryak, and S. R. Patierno. 2003. Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem. 278:17885-17894.
18. Ha, L., S. Ceryak, and S. R. Patierno. 2004. Generation of S phase-dependent DNA double strand breaks by Cr(VI) exposure: involvement of ATM in Cr(VI) induction of γ-H2AX. Carcinogenesis 25:2265-2274.
19. Hickman, M. J., and L. D. Samson. 2004. Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. Mol. Cell 14:105-116.
20. Hickman, M. J., and L. D. Samson. 1999. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. USA 96:10764-10769.
21. Hirose, T., K. Kondo, Y. Takahashi, H. Ishikura, H. Fujino, M. Tsuyuguchi, M. Hashimoto, T. Yokose, K. Mukai, T. Kodama, and Y. Monden. 2002. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol. Carcinogenesis. 33:172-180.
22. Hoeijmakers, J. H. 2001. Genome maintenance mechanisms for preventing cancer. Nature 411:366-374.
23. Huang, X., M. Okafuji, F. Traganos, E. Luther, E. Holden, and Z. Darzynkiewicz. 2004. Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin. Cytometry A 58A:99-110.
24. Hwang, A., A. Maity, W. G. McKenna, and R. J. Muschel. 1995. Cell cycle-dependent regulation of the cyclin B1 promoter. J. Biol. Chem. 270:28419-28424.
25. Jin, Y. H., A. B. Clark, R. J. Slebos, H. Al-Refai, J. A. Taylor, T. A. Kunkel, M. A. Resnick, and D. A. Gordenin. 2003. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat. Genet. 34:326-329.
26. Jiricny, J., and M. Nystrom-Lahti. 2000. Mismatch repair defects in cancer. Curr. Opin. Genet. Dev. 10:157-161.
27. Karran, P. 2001. Mechanisms of tolerance to DNA damaging therapeutic drugs. Carcinogenesis 22:1931-1937.
28. Kolodner, R. D. 1996. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65:101-133.
29. Kolodner, R. D., and G. T. Marsischky. 1999. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 9:89-96.
30. Kondo, K., N. Hino, M. Sasa, Y. Kamamura, S. Sakiyama, M. Tsuyuguchi, M. Hashimoto, T. Uyama, and Y. Monden. 1997. Mutations of the p53 gene in human lung cancer from chromate-exposed workers. Biochem. Biophys. Res. Commun. 239:95-100.
31. Kortenkamp, A., M. Casadevall, and P. Da Cruz Fresco. 1996. The reductive conversion of the carcinogen chromium (VI) and its role in the formation of DNA lesions. Ann. Clin. Lab. Sci. 26:160-175.
32. Langard, S. 1990. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17:189-215.
33. Lin, D. P., Y. Wang, S. J. Scherer, A. B. Clark, K. Yang, E. Avdievich, B. Jin, U. Werling, T. Parris, N. Kurihara, A. Umar, R. Kucherlapati, M. Lipkin, T. A. Kunkel, and W. Edelmann. 2004. An Msh2 point mutation uncouples DNA mismatch repair and apoptosis. Cancer Res. 64:517-522.
34. Mattagajasingh, S. N., and H. P. Misra. 1999. Analysis of EDTA-chelatable proteins from DNA-protein crosslinks induced by a carcinogenic chromium(VI) in cultured intact human cells. Mol. Cell. Biochem. 199:149-162.
35. Mellon, I., D. K. Rajpal, M. Koi, C. R. Boland, and G. N. Champe. 1996. Transcription-coupled repair deficiency and mutations in human mismatch repair genes. Science 272:557-560.
36. O'Brien, T., H. G. Mandel, D. E. Pritchard, and S. R. Patierno. 2002. Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions. Biochemistry 41:12529-12537.
37. O'Brien, T., J. Xu, and S. R. Patierno. 2001. Effects of glutathione on chromium-induced DNA crosslinking and DNA polymerase arrest. Mol. Cell. Biochem. 222:173-182.
38. Ochs, K., and B. Kaina. 2000. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent. Cancer Res. 60:5815-5824.
39. Papouli, E., P. Cejka, and J. Jiricny. 2004. Dependence of the cytotoxicity of DNA-damaging agents on the mismatch repair status of human cells. Cancer Res. 64:3391-3394.
40. Park, J. S., E. J. Kim, J. Y. Lee, H. S. Sin, S. E. Namkoong, and S. J. Um. 2001. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins. Int. J. Cancer 91:822-827.
41. Prolla, T. A., S. M. Baker, A. C. Harris, J. L. Tsao, X. Yao, C. E. Bronner, B. Zheng, M. Gordon, J. Reneker, N. Arnheim, D. Shibata, A. Bradley, and R. M. Liskay. 1998. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat. Genet. 18:276-279.
42. Quievryn, G., J. Messer, and A. Zhitkovich. 2002. Carcinogenic chromium(VI) induces cross-linking of vitamin C to DNA in vitro and in human lung A549 cells. Biochemistry 41:3156-3167.
43. Quievryn, G., E. Peterson, J. Messer, and A. Zhitkovich. 2003. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry 42:1062-1070.
44. Reynolds, M., E. Peterson, G. Quievryn, and A. Zhitkovich. 2004. Human nucleotide excision repair efficiently removes chromium-DNA phosphate adducts and protects cells against chromate toxicity. J. Biol. Chem. 279:30419-30424.
45. Rogakou, E. P., C. Boon, C. Redon, and W. M. Bonner. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146:905-916.
46. Sherwood, S. W., D. F. Rush, A. L. Kung, and R. T. Schimke. 1994. Cyclin B1 expression in HeLa S3 cells studied by flow cytometry. Exp. Cell Res. 211:275-281.
47. Shimodaira, H., A. Yoshioka-Yamashita, R. D. Kolodner, and J. Y. Wang. 2003. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc. Natl. Acad. Sci. USA 100:2420-2425.
48. Sogo, J. M., M. Lopes, and M. Foiani. 2002. Fork reversal and ssDNA accumulation at stalled replication forks owing to checkpoint defects. Science 297:599-602.
49. Stojic, L., N. Mojas, P. Cejka, M. Di Pietro, S. Ferrari, G. Marra, and J. Jiricny. 2004. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev. 18:1331-1344.
50. Strauss-Soukup, J. K., M. M. Vaghefi, R. I. Hogrefe, and L. J. Maher, 3rd. 1997. Effects of neutralization pattern and stereochemistry on DNA bending by methylphosphonate substitutions. Biochemistry 36:8692-8698.
51. Suzuki, Y., and K. Fukuda. 1990. Reduction of hexavalent chromium by ascorbic acid and glutathione with special reference to the rat lung. Arch. Toxicol. 64:169-176.
52. Taioli, E., A. Zhitkovich, P. Kinney, I. Udasin, P. Toniolo, and M. Costa. 1995. Increased DNA-protein crosslinks in lymphocytes of residents living in chromium-contaminated areas. Biol. Trace Elem. Res. 50:175-180.
53. Tsao, J. L., Y. Yatabe, R. Salovaara, H. J. Jarvinen, J. P. Mecklin, L. A. Aaltonen, S. Tavare, and D. Shibata. 2000. Genetic reconstruction of individual colorectal tumor histories. Proc. Natl. Acad. Sci. USA 97:1236-1241.
54. Tsou, T. C., H. J. Lai, and J. L. Yang. 1999. Effects of mannitol or catalase on the generation of reactive oxygen species leading to DNA damage by chromium(VI) reduction with ascorbate. Chem. Res. Toxicol. 12:1002-1009.
55. Voitkun, V., A. Zhitkovich, and M. Costa. 1998. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res. 26:2024-2030.
56. Wang, S., and X. Shi. 2001. Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK. Carcinogenesis 22:757-762.
57. Wang, Y., D. Cortez, P. Yazdi, N. Neff, S. J. Elledge, and J. Qin. 2000. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:927-939.
58. Wang, Y., and J. Qin. 2003. MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation. Proc. Natl. Acad. Sci. USA 100:15387-15392.
59. Watanabe, Y., A. Haugen-Strano, A. Umar, K. Yamada, H. Hemmi, Y. Kikuchi, S. Takano, Y. Shibata, J. C. Barrett, T. A. Kunkel, and M. Koi. 2000. Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer. Mol. Carcinog. 29:37-49.
60. Wheeler, J. M., W. F. Bodmer, and N. J. Mortensen. 2000. DNA mismatch repair genes and colorectal cancer. Gut 47:148-153.
61. Yang, G., S. J. Scherer, S. S. Shell, K. Yang, M. Kim, M. Lipkin, R. Kucherlapati, R. D. Kolodner, and W. Edelmann. 2004. Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility. Cancer Cell 6:139-150.
62. Ye, J., S. Wang, S. S. Leonard, Y. Sun, L. Butterworth, J. Antonini, M. Ding, Y. Rojanasakul, V. Vallyathan, V. Castranova, and X. Shi. 1999. Role of reactive oxygen species and p53 in chromium(VI)-induced apoptosis. J. Biol. Chem. 274:34974-34980.
63. Zhitkovich, A., Y. Song, G. Quievryn, and V. Voitkun. 2001. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 40:549-560.
64. Zhitkovich, A., V. Voitkun, and M. Costa. 1996. Formation of the amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group. Biochemistry 35:7275-7282.
65. Zhitkovich, A., V. Voitkun, and M. Costa. 1995. Glutathione and free amino acids form stable complexes with DNA following exposure of intact mammalian cells to chromate. Carcinogenesis 16:907-913.